Related Experiment Videos
The menopause and HRT. HRT and cognitive decline
1Laboratory of Personality and Cognition, Gerontology Research Center, National Institute on Aging, NIH, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA.
Summary
Hormone replacement therapy (HRT) shows no harm to cognitive function. While observational studies suggest protection against Alzheimer's disease (AD), randomized trials offer insufficient evidence for HRT use to maintain cognitive health.
Area of Science:
- Neuroscience
- Endocrinology
- Gerontology
Background:
- Hormone replacement therapy (HRT) is biologically plausible to protect against cognitive decline and Alzheimer's disease (AD).
- Previous research has yielded mixed results regarding HRT's impact on cognitive function in women.
Purpose of the Study:
- To review observational and randomized trials on HRT's effect on cognitive decline in women.
- To assess clinical relevance, including treatment duration, type, and patient characteristics.
Main Methods:
- Systematic review and meta-analysis of observational studies and randomized controlled trials.
- Inclusion of studies examining cognitively unimpaired and demented women.
- Analysis of factors like menopause type, age, education, and menopausal symptoms.
Main Results:
- Evidence suggests no detrimental effect of HRT on overall cognitive function.
- Inconsistent benefits observed for verbal memory, reasoning, frontal functions, and speeded attention.
- Observational trials suggest AD protection, but randomized trials show no long-lasting AD benefit.
Conclusions:
- Current evidence is insufficient to recommend HRT for cognitive function maintenance.
- Further research is needed to clarify HRT's role in preventing or treating cognitive decline and AD.